These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aggression, agitation, and mania with olanzapine. John V; Rapp M; Pies R Can J Psychiatry; 1998 Dec; 43(10):1054. PubMed ID: 9868577 [No Abstract] [Full Text] [Related]
11. Case report: possible neuroleptic malignant syndrome associated with olanzapine. Moltz DA; Coeytaux RR J Clin Psychopharmacol; 1998 Dec; 18(6):485-6. PubMed ID: 9864084 [No Abstract] [Full Text] [Related]
12. Propranolol treatment of olanzapine-induced akathisia. Kurzthaler I; Hummer M; Kohl C; Miller C; Fleischhacker WW Am J Psychiatry; 1997 Sep; 154(9):1316. PubMed ID: 9286196 [No Abstract] [Full Text] [Related]
13. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. Levy E; Margolese HC; Chouinard G J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686 [No Abstract] [Full Text] [Related]
14. Neuroleptic malignant syndrome after the initiation of olanzapine. Levenson JL J Clin Psychopharmacol; 1999 Oct; 19(5):477-8. PubMed ID: 10505593 [No Abstract] [Full Text] [Related]
15. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842 [TBL] [Abstract][Full Text] [Related]
16. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis. Finkel B; Lerner A; Oyffe I; Rudinski D; Sigal M; Weizman A Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981 [TBL] [Abstract][Full Text] [Related]